Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study

Author： Kjeldsen Sverre E.   Devereux Richard B.   Hille Darcy A.   Lyle Paulette A.   Dahlöf Björn   Julius Stevo   Edelman Jonathan M.   Snapinn Steven M.   de Faire Ulf   Fyhrquist Frej   Ibsen Hans   Lederballe-Pedersen Ole   Lindholm Lars H.   Nieminen Markku S.   Omvik Per   Oparil Suzanne   Wedel Hans    

Publisher： Informa Healthcare

ISSN： 0803-7051

Source： Blood Pressure, Vol.18, Iss.6, 2009-12, pp. : 348-361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nocturnal blood pressure reduction and development of left ventricular hypertrophy in patients with treated essential hypertension

By Evequoz D.   Zuber M.   Kiowski W.   Erne P.  

European Journal of Internal Medicine, Vol. 10, Iss. 1, 1999-05 ,pp. : 21-26

Elsevier

Access to resources Recommend Favorite

Hypertension, left ventricular hypertrophy and chronic kidney disease

By Taddei Stefano  

Heart Failure Reviews, Vol. 16, Iss. 6, 2011-11 ,pp. : 615-620

Springer Publishing Company

Access to resources Recommend Favorite

The Effects of Simvastatin on Left Ventricular Hypertrophy and Left Ventricular Function in Patients with Essential Hypertension

By Pan Xiu-Di   Zeng Zhao-Hua   Liang Li-Ying   Luo Jian-Dong   Xiao Ai-Yi   Lai Qing   Wen Yan-Hang   Lu Dong-Feng   Wang Wei   He Zhao-Chu   He Wen-Kai  

Clinical and Experimental Hypertension, Vol. 33, Iss. 8, 2011-12 ,pp. : 558-564

Informa Healthcare

Access to resources Recommend Favorite

Influence of regression of left ventricular hypertrophy on left atrial size and function in patients with moderate hypertension

By Mattioli Anna Vittoria   Bonatti Silvia   Monopoli Daniel   Zennaro Mauro   Mattioli Giorgio  

Blood Pressure, Vol. 14, Iss. 5, 2005-10 ,pp. : 273-278

Informa Healthcare

Access to resources Recommend Favorite

Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: The LIFE study

By Reims Henrik   Oparil Suzanne   KJELDSEN Sverre   Devereux Richard   Julius Stevo   Brady William   Fyhrquist Frej   Ibsen Hans   Lindholm Lars   Omvik Per   Wedel Hans   Beevers Gareth   De Faire Ulf   Kristianson Krister   Lederballe-Pedersen Ole   Nieminen Markku   Dahlöf Björn  

Blood Pressure, Vol. 13, Iss. 6, 2004-12 ,pp. : 376-384

Informa Healthcare

Access to resources Recommend Favorite